CAH financials
Cardinal Health, Inc. · end-of-day data as of Oct 16, 2026
Cardinal Health, Inc.
$254.06+11.7%
Buy · 17 analystsPT $265.38 +4.5%
CAH reported revenue of $63.86B for the quarter ended Jun 30, 2026 (Q4 FY2026), up 6.1% from a year earlier. It posted diluted EPS of $1.69, free cash flow of $1.43B and a net margin of 0.6%.
Valuation
- P/E35.1x
- P/E vs own+18.7%
- P/E vs sector+24.8%
- FCF yield+7.7%
- Market cap$58.83B
Quarterly results
Q4 FY2026: Revenue +6.1% year over year, free cash flow 2.2% of revenue, operating margin 1.1%.
RevenueFree cash flow
| Q4 FY2026 | Jun 30, 2026 | $63.86B | 1.69 | $1.43B | 4.3% | 1.1% | 0.6% |
| Q3 FY2026 | Mar 31, 2026 | $60.94B | 1.69 | $1.68B | 4.1% | 0.8% | 0.7% |
| Q2 FY2026 | Dec 31, 2025 | $65.44B | 1.97 | $555M | 3.4% | 1.1% | 0.7% |
| Q1 FY2026 | Sep 30, 2025 | $64.01B | 1.88 | $865M | 3.6% | 1.0% | 0.7% |
| Q4 FY2025 | Jun 30, 2025 | $60.16B | 1.00 | $1.29B | 3.7% | 0.7% | 0.4% |
| Q3 FY2025 | Mar 31, 2025 | $54.88B | 2.10 | $2.79B | 3.9% | 1.3% | 0.9% |
| Q2 FY2025 | Dec 31, 2024 | $55.26B | 1.65 | -$499M | 3.5% | 1.0% | 0.7% |
| Q1 FY2025 | Sep 30, 2024 | $52.28B | 1.70 | -$1.74B | 3.6% | 1.1% | 0.8% |
| Q4 FY2024 | Jun 30, 2024 | $59.71B | 0.96 | $1.88B | 3.1% | 0.7% | 0.4% |
| Q3 FY2024 | Mar 31, 2024 | $54.87B | 1.07 | -$139M | 3.5% | 0.7% | 0.5% |
| Q2 FY2024 | Dec 31, 2023 | $57.44B | 1.50 | $1.06B | 3.2% | 0.9% | 0.6% |
| Q1 FY2024 | Sep 30, 2023 | $54.65B | -0.05 | $436M | 3.2% | -0.1% | 0.0% |